These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7193975)

  • 21. Kinetics of cis-dichlorodiammineplatinum.
    Gormley PE; Bull JM; LeRoy AF; Cysyk R
    Clin Pharmacol Ther; 1979 Mar; 25(3):351-7. PubMed ID: 761445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiological pharmacokinetic modeling of cis-dichlorodiammineplatinum(II) (DDP) in several species.
    King FG; Dedrick RL; Farris FF
    J Pharmacokinet Biopharm; 1986 Apr; 14(2):131-55. PubMed ID: 3746636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacokinetics study of intraperitoneal cisplatin in ovarian carcinoma].
    Han GR; Cai GF
    Zhonghua Fu Chan Ke Za Zhi; 1993 Apr; 28(4):224-6, 254. PubMed ID: 8404307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the intraperitoneal and intravenous routes of cisplatin administration in an advanced ovarian cancer model of the rat.
    Sekiya S; Iwasawa H; Takamizawa H
    Am J Obstet Gynecol; 1985 Sep; 153(1):106-11. PubMed ID: 4041136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platinum tissue concentrations following intra-arterial and intravenous cis-diamminedichloroplatinum II in New Zealand white rabbits.
    Carlson JA; Litterst CL; Greenberg RA; Day TG; Masterson BJ
    Am J Obstet Gynecol; 1984 Feb; 148(3):313-7. PubMed ID: 6538067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo pharmacokinetic and tissue distribution investigation of sustained-release cisplatin implants in the normal esophageal submucosa of 12 beagle dogs.
    Yin JX; Wei Z; Xu JJ; Sun ZQ
    Cancer Chemother Pharmacol; 2015 Sep; 76(3):525-36. PubMed ID: 26183605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of cisplatin.
    Vermorken JB; van der Vijgh WJ; Klein I; Gall HE; van Groeningen CJ; Hart GA; Pinedo HM
    Clin Pharmacol Ther; 1986 Feb; 39(2):136-44. PubMed ID: 3943271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisplatin therapy in 41 dogs with malignant tumors.
    Knapp DW; Richardson RC; Bonney PL; Hahn K
    J Vet Intern Med; 1988; 2(1):41-6. PubMed ID: 3221354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model.
    Cvitkovic E; Spaulding J; Bethune V; Martin J; Whitmore WF
    Cancer; 1977 Apr; 39(4):1357-61. PubMed ID: 856436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combination effects of cis-dichlorodiammineplatinum (II) and sodium thiosulfate on renal dysfunction].
    Hirosawa A; Sakai S; Iizuka K; Niitani H; Hayashibara K; Tsuboi E
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2870-5. PubMed ID: 3662543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients.
    Poirier MC; Reed E; Litterst CL; Katz D; Gupta-Burt S
    Cancer Res; 1992 Jan; 52(1):149-53. PubMed ID: 1727376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive experience of intraperitoneal chemotherapy followed by intravenous chemotherapy in heavily pretreated patients with suboptimal residual ovarian cancer and primary peritoneal cancer.
    Nicoletto MO; Dalla Palma M; Donach ME; Gusella M; Cappetta A; Shams M; Marchet A; Nardin M; Pintacuda G; Di Maggio A; Marchesi M; Carli P; Fiduccia P; Artioli G; Nitti D
    Tumori; 2010; 96(6):918-25. PubMed ID: 21388052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
    Deng C; Huang R; Lian L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):159-62. PubMed ID: 8758790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Model independent pharmacokinetic study of cis-dichlorodiammineplatinum (II).
    Dumas M; d'Athis P; de Gislain C; Escousse A; Guerrin J; Autissier N
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):430-3. PubMed ID: 4044076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fundamental studies on intravesical instillation of cis-diamminedichloroplatinum for treatment of urinary bladder tumors. I: On the effects of intravesical instillation of cis-diamminedichloroplatinum in normal beagle dogs].
    Hirao Y; Iwai A; Yoshie T; Moriya A; Matsuki H; Yoshida K; Sanma S; Kubota K; Ohara S; Babaya K
    Hinyokika Kiyo; 1985 Jan; 31(1):31-8. PubMed ID: 4039525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased tissue deposition and decreased excretion of platinum following administration of cisplatin to cisplatin-pretreated animals.
    Litterst CL; Schweitzer VG
    Cancer Chemother Pharmacol; 1984; 12(1):46-9. PubMed ID: 6537802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy.
    Ostrow S; Egorin M; Aisner J; Bachur N; Wiernik PH
    Cancer Clin Trials; 1980; 3(1):23-7. PubMed ID: 7190082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term consequences of cis-platinum-induced renal injury: a structural and functional study.
    Dobyan DC
    Anat Rec; 1985 Jul; 212(3):239-45. PubMed ID: 4061878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodistribution and dosimetry of 195mPt-cisplatin in normal volunteers. Imaging agent for single photon emission computed tomography.
    Sathekge M; Wagener J; Smith SV; Soni N; Marjanovic-Painter B; Zinn C; Van de Wiele C; D'Asseler Y; Perkins G; Zeevaart JR
    Nuklearmedizin; 2013 Dec; 52(6):222-7. PubMed ID: 24108524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.